Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Bill Anderson's replacement as chief executive of Roche Pharmaceuticals has been announced, with head of global product strategy Teresa Graham stepping up into the role. Anderson's departure was ...

Our trans-disciplinary research activities cover all aspects of modern molecular systems biology: We perform experiments to investigate, quantify and characterise the response/status/output of ...

Submit here Molecular Systems Biology publishes manuscripts on molecular components and their interactions, as well as systems studies at the organ level and works describing large-scale datasets with ...

EMBO Press encourages applying due care in interpreting bibliometric measures such as CiteScore, h5-Index and Journal Impact Factor among others. EMBO is a foundation signatory of the San Francisco ...